Abbott Laboratories Research Note: October 21 Results Put Growth Quality to the Test
Abbott’s October 21 results will test whether medical-device strength can outweigh uneven segments, acquisition costs, leverage and legal exposure.
CAMS Research Desk
CAMS Closing Market Recap: October 19, 2026
The Nasdaq rose 1.11% as Amazon gained 4.98%, but the equal-weight S and P fund fell 0.32%.
Desk Note: Fed Reframes AI Boom as Inflation Shock (Oct 19)
Reuters reports Federal Reserve officials increasingly see AI investment as an inflationary shock, strengthening the link between the technology rebound and further rate risk.
CAMS Midday Market Check: October 19, 2026
By eleven forty-nine Eastern, the Nasdaq rose 1.72%, but eight of 11 sector funds were lower.
Market Structure: Technology rebound tests the defensive rotation (October 19, 2026)
Technology futures rebound after Friday’s sector split, while financing stress, defensive strength and oil risk keep the repair case conditional.
CAMS Morning Market Brief: October 19, 2026
Nasdaq 100 futures climbed 1.16% at six eleven Eastern amid an early technology rebound.
Newmont Corporation Research Note: Cash Strength Meets an Execution Test
Newmont enters its October 22 update with strong cash generation, rising capital intensity, and a crucial test of production, costs, and guidance.
Moderna Research Note: Phase 3 Success Still Needs the Numbers
Moderna’s Phase 3 melanoma study met two key endpoints, but the October 24 data must clarify effect size, durability, safety, and next steps.
Quest Diagnostics Incorporated Research Note: Growth Meets a Margin and Mix Test
Quest Diagnostics enters its October 22 update with strong growth, a complex volume mix and questions about revenue per requisition and margins.
Weekly Market Outlook: Week of October 19, 2026: Inflation and Oil Pressure Break Technology Leadership
Hot inflation, rising oil and financing stress fractured technology leadership, while defensive groups kept sector breadth from collapsing sharply.